Skip to main content

Lab Notes: FDA approves Incyte's vitiligo treatment; Neuronetics gets a 'big win'

A Bucks County biopharma firm has an update on its pursuit of a hepatitis B therapy.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.